| 1 |
33771522 | MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo. | 2021 May 15 |
4 |
| 2 |
34799910 | P1-39: Paclitaxel induces growth inhibition in gefitinib-resistant PC9-MET cells by downregulating MDM2 and activating p53. | 2021 Nov |
1 |
| 3 |
30774764 | Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression. | 2019 Jan 18 |
6 |
| 4 |
26799187 | p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells. | 2016 Feb 16 |
1 |
| 5 |
27659528 | Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway. | 2016 Nov 8 |
1 |
| 6 |
25022573 | MDM2 molecular imaging for the prediction of chemotherapeutic sensitivity in human breast cancer xenograft. | 2014 |
1 |
| 7 |
21556366 | Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel. | 2011 Apr 27 |
3 |
| 8 |
22701761 | Human Oncoprotein MDM2 Up-regulates Expression of NF-κB2 Precursor p100 Conferring a Survival Advantage to Lung Cells. | 2011 Oct |
1 |
| 9 |
19918798 | Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. | 2010 Feb |
3 |
| 10 |
18813780 | Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. | 2008 Oct |
1 |
| 11 |
13130078 | Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy. | 2003 Sep 30 |
2 |
| 12 |
11025661 | p53 is associated with cellular microtubules and is transported to the nucleus by dynein. | 2000 Oct |
1 |